Boehringer Ingelheim Obesity Drug Shows Fat-Specific Weight Loss in Late-Stage Trial

Late-stage trial results for Boehringer Ingelheim's obesity drug indicate that it helps patients lose fat rather than muscle, a key finding for weight-loss treatments.

30 Apr, 06:17 — 30 Apr, 06:17

Post Share

Sources

Showing 1 of 1 sources

wsjHigh122d ago

Boehringer Ingelheim’s Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows - WSJ

Boehringer Ingelheim’s Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows WSJ

Read full article →

Boehringer Ingelheim Obesity Drug Shows Fat-Specific Weight Loss in Late-Stage Trial

Sources

Boehringer Ingelheim’s Obesity Drug Helps Lose Fat Rather Than Muscle, Late-Stage Trial Shows - WSJ

Related Stories

NASA Launches Nancy Grace Roman Space Telescope to Probe Dark Energy and Hidden Worlds

NASA Launches Nancy Grace Roman Space Telescope on Planet-Hunting Mission

Scientists Investigate Herpes Virus Link to Mass Sardine Die-Off Off South Africa

Partial Lunar Eclipse Captured by Stargazers Across Multiple Continents